Bipartisan Overhaul Of Rx Benefit Cos. Stalls At Senate Panel

A Senate committee on Tuesday temporarily postponed consideration of legislation that would crack down on the intermediaries between drugmakers and insurers known as pharmacy benefit managers, setting up a vote next...

Already a subscriber? Click here to view full article